Listed

IGC Pharma, Inc.: Form 10-Q for the period ended Sep 30, 2011

Filed with the SEC on Nov 18, 2011 and accepted by EDGAR at Nov 18, 2011, 17:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-07-01 to 2011-09-30$912.1kus-gaap:Revenues
Revenue6 months2011-04-01 to 2011-09-30$2.0mus-gaap:Revenues
Cost of revenue3 months2011-07-01 to 2011-09-30$903.5kus-gaap:CostOfRevenue
Cost of revenue6 months2011-04-01 to 2011-09-30$1.9mus-gaap:CostOfRevenue
Selling, general and administrative3 months2011-07-01 to 2011-09-30$652.4kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2011-04-01 to 2011-09-30$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2011-07-01 to 2011-09-30−$719.4kus-gaap:OperatingIncomeLoss
Operating income6 months2011-04-01 to 2011-09-30−$1.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-07-01 to 2011-09-30$149.0kus-gaap:InterestExpense
Interest expense6 months2011-04-01 to 2011-09-30$449.7kus-gaap:InterestExpense
Net income3 months2011-07-01 to 2011-09-30−$789.3kus-gaap:NetIncomeLoss
Net income6 months2011-04-01 to 2011-09-30−$1.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-07-01 to 2011-09-30−$0.04us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2011-04-01 to 2011-09-30−$0.08us-gaap:EarningsPerShareDiluted
Basic EPS3 months2011-07-01 to 2011-09-30−$0.04us-gaap:EarningsPerShareBasic
Basic EPS6 months2011-04-01 to 2011-09-30−$0.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2011-07-01 to 2011-09-3020,960,433 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2011-04-01 to 2011-09-3020,699,660 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2011-04-01 to 2011-09-30−$813.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-09-30$766.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-09-30$5.8mus-gaap:AssetsCurrent
Total assetsAt period end2011-09-30$16.1mus-gaap:Assets
Current liabilitiesAt period end2011-09-30$6.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-09-30$6.7mus-gaap:Liabilities
Short-term borrowingsAt period end2011-09-30$818.5kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2011-09-30$5.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-11-002076. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.